Lexicon Pharmaceuticals
LXRX
#6613
Rank
โ‚ฌ0.59 B
Marketcap
1,41ย โ‚ฌ
Share price
5.13%
Change (1 day)
232.05%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): -0,18ย โ‚ฌ

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -0,16ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -0,55ย โ‚ฌ an increase over its 2023 EPS that were of -0,69ย โ‚ฌ.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-0,18ย โ‚ฌ-67.98%
2024-0,55ย โ‚ฌ-20%
2023-0,69ย โ‚ฌ31.15%
2022-0,53ย โ‚ฌ-0%
2021-0,53ย โ‚ฌ10.91%
2020-0,47ย โ‚ฌ-145.08%
20191,05ย โ‚ฌ-206.09%
2018-0,99ย โ‚ฌ-5.74%
2017-1,05ย โ‚ฌ-10.95%
2016-1,18ย โ‚ฌ2640%
2015-0,04313ย โ‚ฌ-96.34%
2014-1,18ย โ‚ฌ-2.53%
2013-1,21ย โ‚ฌ-9.09%
2012-1,33ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
15,33ย โ‚ฌ-9,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
4,73ย โ‚ฌ-2,984.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
37,20ย โ‚ฌ-22,794.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-5,04ย โ‚ฌ 2,973.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
5,44ย โ‚ฌ-3,415.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-0,43ย โ‚ฌ 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-0,65ย โ‚ฌ 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
1,57ย โ‚ฌ-1,057.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-66,18ย โ‚ฌ 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA